Searched for
ERIS LIFESCIENCES SHARE
Dividend alert! Last date to buy Bajaj Auto, GSK Pharma and 10 other stocks for solid payouts. Details hereTwelve companies are set to go ex-dividend on Friday, offering shareholders payouts totaling over Rs 250. Bajaj Auto leads with a Rs 150 pe...- Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...
- Eris Lifesciences among 5 stocks showing bullish RSI upswingFive Nifty500 stocks featured in the RSI Trending Up scan on May 20 after gaining over 5%. The RSI moved above the 50 mark from lower level...
- Crorepati investors splurge $1 billion to buy these 10 stocks. Should you follow the smart money?Wealthy investors are making significant moves, pouring over $1 billion into ten select stocks. This concentrated buying occurs even as the...
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
- Natco Pharma, Eris Lifesciences shares jump up to 6% on partnership for Semaglutide launch in IndiaShares of Natco Pharma and Eris Lifesciences climbed on Tuesday after announcing a partnership to commercialise Semaglutide in India. Natco...
- Eris Lifesciences shares in focus on move to acquire Swiss Parenterals in Rs 423 crore dealEris Lifesciences is set to fully acquire its injectable unit, Swiss Parenterals. The deal involves a share swap valued at Rs 423.3 crore. ...
- Eris Lifesciences' unit gets Brazil health regulator nodEris Lifesciences announced that its Ahmedabad manufacturing facility secured approval from ANVISA, Brazil's health regulatory agency, foll...
- Eris Lifesciences Q1 Results: Net dips 4.5% YoY at Rs 89 croreEris Lifesciences on Friday said its consolidated profit after tax declined by 4.5 per cent year on year to Rs 89 crore for the quarter end...
- Eris acquires 51 pc stake in Swiss Parenterals for Rs 637.5 crEris Lifesciences on Tuesday said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore. Ahmedabad-based Swiss Parent...
- Buy Eris Lifesciences, target price Rs 710: Motilal Oswal Financial ServicesEris Lifesciences, incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 7871.82 Crore) operating in Pharmaceutica...
- Eris Lifesciences acquires 9 dermatology brands from Dr Reddy's for Rs 275 crThe transaction will be financed through borrowings and will achieve financial closure in the next few days, the drug firm said. In a separ...
- Buy Eris Lifesciences, target price Rs 850: Prabhudas LilladherEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 8921.10 Crore) operating in Pharmace...
- Eris Lifesciences jumps 10% as investors cheer JV with MJ BiopharmThe JV, dubbed Eris Biopharm, would be in the ratio of 70:30, with Eris holding a 70 per cent stake.
- Eris Lifesciences Q3 results: Net profit up 42% at Rs 90 croreConsolidated total revenue from operations of the company stood at Rs 310.42 crore for the quarter under consideration. It was Rs 266.39 cr...
- Eris Lifesciences Q2 results: Net profit up 16% at Rs 108 crTotal revenue from operations stood at Rs 329.99 crore for the quarter under consideration. It was Rs 284.79 crore for the same period year...
- Buy Eris Lifesciences, target price Rs 690: Haitong SecuritiesThe brokerage values Eris at a 20 per cent premium to its mid-cap peers.
- Accumulate Eris Lifesciences, target Rs 704: Prabhudas LilladherAccumulate Eris Lifesciences Ltd. at a price target of Rs 704.
- Eris Lifesciences, Shasun Strides shares rise on Rs 500 crore dealThe India branded generics business being divested by Strides had sales of Rs 181 core FY 2017, the statement said.
- Eris Lifesciences sets IPO price band in Rs 600-603 rangeThe shareholders of the company plans to sell 28,875,000 equity shares.
Load More
